CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
2.940
-0.180 (-5.77%)
At close: Jun 5, 2026, 4:00 PM EDT
2.970
+0.030 (1.02%)
After-hours: Jun 5, 2026, 5:11 PM EDT
CervoMed Employees
CervoMed had 15 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
15
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$139,268
Profits / Employee
-$2,002,433
Market Cap
27.22M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 15 | 0 | - |
| Dec 31, 2024 | 15 | 7 | 87.50% |
| Dec 31, 2023 | 8 | 4 | 100.00% |
| Mar 31, 2023 | 4 | - | - |
| Dec 31, 2022 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| IGC Pharma | 70 |
| Kyntra Bio | 34 |
| Daré Bioscience | 24 |
| Quantum BioPharma | 17 |
| NeuroSense Therapeutics | 17 |
| BriaCell Therapeutics | 16 |
| Serina Therapeutics | 16 |
| Barinthus Biotherapeutics | 14 |
CRVO News
- 19 days ago - CervoMed price target lowered to $9 from $11 at Roth Capital - TheFly
- 20 days ago - CervoMed Reports First Quarter 2026 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 23 days ago - CervoMed Quarterly report: Q1 2026 - Filings
- 23 days ago - CervoMed Earnings release: Q1 2026 - Filings
- 5 weeks ago - CervoMed Proxy statement: Proxy filing - Filings
- 6 weeks ago - CervoMed presents neflamapimod MRI data - TheFly
- 6 weeks ago - CervoMed Announces New Data at the 2026 AAN Annual Meeting that Demonstrated Neflamapimod Increased Basal Forebrain Volume and Functional Connectivity in Dementia with Lewy Bodies - GlobeNewsWire
- 2 months ago - CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting - GlobeNewsWire